HIGHLIGHTS
- who: Alessia Floerchinger from the (UNIVERSITY) have published the Article: A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors, in the Journal: (JOURNAL) of 20/01/2023
- what: This study provides proof-of-concept for MV-BiKE as a novel immunovirotherapy to harness virus-activated NK cells as anti-tumor effectors. The authors report stimulation of human healthy donor NK cells exposed to MV-infected colorectal or pancreatic cancer cells, as indicated by increased CD69 expression compared to mock-infected controls. This study shows that NK cell effector . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.